Microbially Produced Imidazole Propionate Is Associated With Heart Failure and Mortality

2. Zero hunger Heart Failure Diabetes Mellitus, Type 2 imidazole propionate microbiota Imidazoles 610 heart failure Humans Stroke Volume histidine Ecosystem 3. Good health
DOI: 10.1016/j.jchf.2023.03.008 Publication Date: 2023-04-26T18:37:33Z
ABSTRACT
Over the past years, it has become clear that the microbial ecosystem in the gut has a profound capacity to interact with the host through the production of a wide range of bioactive metabolites. The microbially produced metabolite imidazole propionate (ImP) is clinically and mechanistically linked with insulin resistance and type 2 diabetes, but it is unclear how ImP is associated with heart failure.The authors aimed to explore whether ImP is associated with heart failure and mortality.ImP serum measurements in 2 large and independent clinical cohorts of patients (European [n = 1,985] and North American [n = 2,155]) with a range of severity of cardiovascular disease including heart failure. Univariate and multivariate Cox regression analyses were performed to delineate the impact of ImP on 5-year mortality in the North American cohort, independent of other covariates.ImP is independently associated with reduced ejection fraction and heart failure in both cohorts, even after adjusting for traditional risk factors. Elevated ImP was a significant independent predictor of 5-year mortality (for the highest quartile, adjusted HR: 1.85 [95% CI: 1.20-2.88]; P < 0.01).The gut microbial metabolite ImP is increased in individuals with heart failure and is a predictor of overall survival.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (58)
CITATIONS (23)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....